Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to the results from a Phase III international clinical trial.
Three presentations at the 95th Annual Meeting of the American Association for Thoracic Surgery suggest that lung cancer surgery patients are at higher risk of developing venous thrombo-embolism, including deep vein thrombosis and pulmonary embolism, than previously thought.
Despite the the efficacy of lung volume reduction surgery (LVRS), its adoption for severe emphysema has been exceedingly poor. A new Columbia University study finds that minimally invasive LVRS can be performed with negligible surgical mortality risk.
After stopping steroids commonly prescribed for asthma and allergies, a significant number of people may experience signs of malfunctioning in the adrenal glands, a European study finds.
Drawing inspiration from veterinary medicine, researchers at the SA Tuberculosis Vaccine Initiative, the University of Cape Town and the University of Washington, have developed a new approach to detect tuberculosis (TB) – easy-to-obtain oral swab samples.
A medical student on work experience has made a breakthrough in cystic fibrosis research that will improve treatment and could extend sufferers’ life expectancy....